About Akonni
Akonni is a company based in Frederick (United States) founded in 2003.. Akonni has raised $39.75 million across 50 funding rounds from investors including NIH, HHS and Ojp. The company has 12 employees as of December 31, 2022. Akonni offers products and services including TruTip Nucleic Acid Universal Kit, TruPrepR Automated Sample Preparation System, and TruDiagnosis. Akonni operates in a competitive market with competitors including Somalogic, Nautilus Biotechnology, Inflammatix, Amunix and Visby Medical, among others.
- Headquarter Frederick, United States
- Employees 12 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Akonni Biosystems, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$39.75 M (USD)
in 50 rounds
-
Latest Funding Round
$168.09 K (USD), Grant
Sep 20, 2021
-
Investors
NIH
& 5 more
-
Employee Count
12
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Akonni
Akonni offers a comprehensive portfolio of products and services, including TruTip Nucleic Acid Universal Kit, TruPrepR Automated Sample Preparation System, and TruDiagnosis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Robust technology for high-yield DNA and RNA extraction.
System providing higher purity for nucleic acid processing.
Integrated system for rapid multiplexed disease analysis.
Unlock access to complete
Unlock access to complete
Funding Insights of Akonni
Akonni has successfully raised a total of $39.75M across 50 strategic funding rounds. The most recent funding activity was a Grant round of $168.09 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 50
- Last Round Grant — $168,087
-
First Round
First Round
(01 Jul 2003)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Grant - Akonni | Valuation |
investors |
|
| Apr, 2021 | Amount | Grant - Akonni | Valuation |
investors |
|
| Jun, 2019 | Amount | Series C - Akonni | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Akonni
Akonni has secured backing from 6 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Ojp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Righton is associated with a brand presence online.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Akonni
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Akonni
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Akonni Comparisons
Competitors of Akonni
Akonni operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Nautilus Biotechnology, Inflammatix, Amunix and Visby Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein-based assays are developed for life science research.
|
|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Akonni
Frequently Asked Questions about Akonni
When was Akonni founded?
Akonni was founded in 2003.
Where is Akonni located?
Akonni is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.
Is Akonni a funded company?
Akonni is a funded company, having raised a total of $39.75M across 50 funding rounds to date. The company's 1st funding round was a Series C of $1.78M, raised on Jul 01, 2003.
How many employees does Akonni have?
As of Dec 31, 2022, the latest employee count at Akonni is 12.
What does Akonni do?
Akonni Biosystem was founded in 2003 in Frederick, United States, and operates in the molecular diagnostics sector. Integrated systems for detecting complex infectious diseases, such as Methicillin-resistant Staphylococcus aureus, multi-drug-resistant tuberculosis, and oseltamivir-resistant influenza, are manufactured and marketed. The gel-drop microarray platform is utilized, with diagnostic tests and transportable readers provided for point-of-care applications in human health.
Who are the top competitors of Akonni?
Akonni's top competitors include Somalogic, Visby Medical and Inflammatix.
What products or services does Akonni offer?
Akonni offers TruTip Nucleic Acid Universal Kit, TruPrepR Automated Sample Preparation System, and TruDiagnosis.
Who are Akonni's investors?
Akonni has 6 investors. Key investors include NIH, HHS, Ojp, Righton, and National Science Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.